Noah Beerman COO at Coronado
This article was originally published in Scrip
Executive Summary
Coronado Biosciences has appointed Noah Beerman executive vice-president and chief operating officer. Mr Beerman has over 25 years' experience in the biopharmaceutical industry and joined Coronado as a consultant in May 2011. Prior to this, he was president and CEO at Galena Biopharma (previously RXi Pharmaceuticals).